Mustang Bio falls after announcement of reverse stock split
** Shares of cancer therapy developer Mustang Bio MBIO.O
fall 32.1% to 15 cents premarket
** MBIO says it will implement 1-for-50 reverse stock split,
which will be effective on Jan. 16
** Co says outstanding shares will decrease from ~64.8 mln
to ~1.3 mln
** MBIO fell 86.4% in 2024
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
Recent news on Mustang Bio
See all newsAdvisory: Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn
U.S. STOCKS ON THE MOVE-Dow, Phibro, Mustang Bio
Mustang soars on FDA's orphan drug tag for brain cancer therapy
Mustang Bio Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Mustang Bio Inc - Enters Sale And Surrender Agreement With Abbvie